Maggi Ahmed, MD, PhD, demonstrated superior pigmentation outcomes and reduced CD8+ T cell numbers in her recent research results.

Click here to answer our poll and let us know what disease states, topics, and research you most want to see news about throughout the conference.

Read more on what you can expect at this year’s AAD meeting and how to navigate all the opportunities.

Kelly M. Cordoro, MD, shared tips on implementing shared decision making in pediatric dermatology dermatology atat annual conference.

Dermatology Times chatted with Sonya Kenkare, MD, FAAD, for tips on navigating the annual meeting.

We've rounded up commentary from trusted dermatology experts who expressed enthusiasm and excitement for the biggest dermatology meeting of the year.

The organization celebrates 2 decades of leading awareness, research, education, membership, and advocacy for clinicians and patients with skin of color.

Among the many sessions to be held at the American Academy of Dermatology Annual Meeting in San Diego, California, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

There are several events in conjunction with AAD featuring opportunities for dermatology clinicians to gain CME credit, network, explore career options, and gain pearls to put into practice.

We want to know: Will you be attending the conference in San Diego later this week?

Dermatology Times asked our readers to share what conferences they are looking forward to in the first quarter of 2024.

Late-breaking phase 2 data was presented at the 2024 American Academy of Allergy, Asthma and Immunology Annual Meeting.

Data on pigmentary disorders worldwide and clinical study results were presented at the IMCAS World Congress 2024 meeting.

Explore Dermatology Times' coverage of the 2024 Masterclasses in Dermatology conference on topics ranging from artificial intelligence lessons from GI to cardiovascular considerations in psoriasis treatment.

Katherine Economy, MD, discusses the challenges and opportunities of treating pregnant patients with dermatologic conditions, emphasizing the importance of comprehensive medication reviews, patient-centered decision-making, and the need for including pregnant patients in clinical trials.

Joel Gelfand, MD, explained how body surface area on patients with psoriasis plays a pivotal role in cardiovascular outcomes.

Daniel Siegel, MD, shared strategies to manage surgery challenges, especially bleeding, to ensure a smooth experience for patients.

David Fisher, MD, PhD, shared pearls on fundamental biology of hair follicles, the dynamics of melanocyte stem cells, and the impact of stress on hair pigmentation.

Discover the evolving landscape of lupus treatment, from the importance of monitoring vitamin D levels to advancements in emerging therapies targeting type 1 interferon and plasmacytoid dendritic cells.

A poster presentation explored the transformative impact of integrating clinical pharmacists into an outpatient dermatology clinic, emphasizing collaborative efforts to enhance patient care and improve outcomes in biologic therapy.